I’ll create a factual news article based on the press release in the Wall Street Journal style, following all your guidelines.

Published 13/06/2025, 08:06
I’ll create a factual news article based on the press release in the Wall Street Journal style, following all your guidelines.

IXICO awards share options to executives amid retention strategy

LONDON - IXICO plc (AIM:IXI), a medical imaging analytics company focused on neurosciences, has granted 850,000 share options to three executives, according to a press release statement issued Friday.

The options were awarded to Chief Technology Officer Mark Austin, Chief Business Officer James Chandler, and VP Global Business Development Terry Reilly. Austin and Chandler are classified as Persons Discharging Managerial Responsibility under Market Abuse Regulation.

The share options include vesting criteria tied to retention and annual share price growth over a three-year period. Options awarded to non-PDMR executives carry an exercise price matching the closing share price on the award date, while those granted to PDMRs have an exercise price of £0.01.

All options are subject to a mandatory hold period until the third anniversary of their award date.

Performance metrics for the options are based on share price growth, measured by calculating the three-month average share price immediately before each anniversary of the option award. The growth targets can be fully achieved through an absolute annual compound share price growth of 40% over three years, or partially through 40% growth compared to the previous year.

Separately, the company reported that Chief Financial and Operating Officer Grant Nash conducted a "bed and ISA" transaction on June 12, selling 45,263 ordinary shares and immediately repurchasing the same number into his Individual Savings Account. This transaction resulted in no change to Nash’s overall beneficial ownership in the company.

IXICO specializes in providing imaging analytics for neuroscience applications.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.